EDGAR Filing Documents for 0001479290-19-000030

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001479290-19-000030

Filing Date

2019-02-28

Accepted

2019-02-28 17:21:38

Documents

Period of Report

2018-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	rvnc1231201810k.htm iXBRL	10-K	2961686
2	EXHIBIT 10.27	rvnc1231201810kex1027.htm	EX-10.27	14153
3	EXHIBIT 10.28	rvnc1231201810kex1028.htm	EX-10.28	4181
4	EXHIBIT 10.37	rvnc1231201810kex1037.htm	EX-10.37	37688
5	EXHIBIT 10.38	rvnc1231201810kex1038.htm	EX-10.38	8162
6	EXHIBIT 10.42	rvnc1231201810kex1042.htm	EX-10.42	440131
7	EXHIBIT 21.1	rvnc1231201810kex2101.htm	EX-21.1	1515
8	EXHIBIT 23.1	rvnc1231201810kex2301.htm	EX-23.1	3035
9	EXHIBIT 31.1	rvnc1231201810kex3101.htm	EX-31.1	9109
10	EXHIBIT 31.2	rvnc1231201810kex3102.htm	EX-31.2	9245
11	EXHIBIT 32.1	rvnc1231201810kex3201.htm	EX-32.1	7213
12	EXHIBIT 32.2	rvnc1231201810kex3202.htm	EX-32.2	7182
18	PIPELINESUMMARY_IMAGE	pipelinesummary_image.jpg	GRAPHIC	79763
19	RVNC12312018KEX1042_IMAGE	rvnc1231201810kex1042_image.jpg	GRAPHIC	9252
20	STOCKPRICEPERFORMANCEGRAPH	stockpriceperformancegraph.jpg	GRAPHIC	83026
	Complete submission text file	0001479290-19-000030.txt		12369728

Data Files

Seq	Description	Document	Type	Size
13	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	rvnc-20181231.xsd	EX-101.SCH	58043
14	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	rvnc-20181231_cal.xml	EX-101.CAL	83367
15	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	rvnc-20181231_def.xml	EX-101.DEF	374999
16	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	rvnc-20181231_lab.xml	EX-101.LAB	874512
17	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	rvnc-20181231_pre.xml	EX-101.PRE	540141
21	EXTRACTED XBRL INSTANCE DOCUMENT	rvnc1231201810k_htm.xml	XML	2146774

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560

Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400

Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)